Ta or CIS: Can include both low and non-muscle invasive, high grade non-muscle invasive bladder cancer (NMIBC), or Carcinoma in Situ (CIS)

Mark Story
Director of Communications and Marketing
mstory@bcan.org | 301-215-9099